NCT03664895 2023-12-04
Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)
Seoul National University Hospital
Phase 3 Unknown
Clinical Trials
16 trialsNCT05800197 2023-04-06
NEMO
Blokhin's Russian Cancer Research Center
Unknown
NCT02914158 2023-01-17
ASPAIT
First Affiliated Hospital, Sun Yat-Sen University
Phase 3 Unknown
NCT05439499 2022-07-06
This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.
Ahon Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT05438810 2022-07-05
This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c in Combination With Fluvestrant ± Goseraline Versus Placebo Combined With Fulvestrant ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.
Ahon Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT05253066 2022-02-23
Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer
Shengjing Hospital
Phase 2/3 Unknown
NCT02626507 2022-02-09
Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer
Hoffman Oncology
Phase 1 Unknown
NCT03591549 2018-07-23
Fulvestrant in Metastatic Breast Cancer
Assiut University
Phase 4 Unknown
NCT03444025 2018-02-23
NeoGONT
Kasr El Aini Hospital
Phase 2 Unknown
NCT01266213 2017-05-01
FLAG
Samsung Medical Center
Phase 2 Unknown
NCT02132390 2014-06-04
Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea
Peking Union Medical College Hospital
Phase 3 Unknown
NCT02072512 2014-02-26
PROOF
Hospital Affiliated to Military Medical Science, Beijing
Phase 2 Unknown
NCT00002460 2013-08-07
Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00398489 2010-11-09
Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00912548 2009-06-16
ASTRRA
Korean Breast Cancer Study Group
Phase 3 Unknown
NCT00488722 2007-06-26
A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer
Tianjin Medical University
Phase NA Unknown